$TSBK

Timberland Bancorp Reports 9% Rise in Quarterly EPS, Expands Net Interest Margin and Raises Dividend

Timberland Bancorp (NASDAQ: TSBK) reported Q2 2026 net income of $7.72 million, or $0.98 diluted EPS, up 9% from $0.90 a year earlier. Net interest margin rose to 3.85%. The company increased its quarterly cash dividend by 3% to $0.30 per share, payable Aug. 24, 2026. Nine-month net income rose 11% to $23.07 million.

Original reporting
Published Jul 28, 2026, 11:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 29, 2026, 3:24 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Timberland Bancorp Reports 9% Rise in Quarterly EPS, Expands Net Interest Margin and Raises Dividend — source image
Decision brief

The 30-second read

$TSBKBullishMed
01

Why it matters

The combination of EPS growth, NIM expansion, improved efficiency ratio, stable credit metrics, and a dividend increase provides a clear set of catalysts that can influence valuation and near-term positioning.

02

Market read

Investors typically reprice regional banks on NIM trajectory, deposit/loan growth, credit quality, and capital return; this release updates all four with specific figures.

03

What to watch

The text truncates before full NIM drivers and credit/provision details; traders should verify whether loan growth and non-performing asset trends translate into sustainable net interest income and reserves.

Relevance 8/10Novelty 7/10Timing: after-hours earnings and dividend announcement (published 2026-07-28)

Background

Timberland Bancorp is the holding company for Timberland Bank; the release covers quarter ended June 30, 2026 with earnings, balance sheet, and capital return updates.

Company-level read

Ticker impact

$TSBKBullishMedium confidence
Context

Timberland Bancorp reported quarterly EPS up 9% to $0.98, NIM up to 3.85%, and announced a 3% dividend increase to $0.30 per share.

Expected impact

Likely modest positive reaction and support for dip-buying, assuming the market focuses on NIM expansion and dividend sustainability.

Evidence & confidence

The article provides multiple same-quarter operating improvements (EPS, NIM, efficiency) and a concrete capital return action (3% dividend increase) with stated credit quality stability, which are typically supportive for regional bank valuations.

Market effects

Regional banks can see read-across from NIM expansion and deposit pricing discipline, reinforcing the narrative that funding costs are being managed.

Local/regional lender sentiment may improve if investors view credit quality as stable alongside margin gains.

Limited global impact; this is primarily a single-bank earnings and capital return update.

Counterpoint

Margin gains may be partly driven by one-time NIM items (prepayment penalties, late fees, and acquired-loan accretion), which could fade.

Key entities

  • Timberland Bancorp, Inc.

    NASDAQ-listed holding company reporting Q2 2026 results and raising its quarterly cash dividend.

  • Timberland Bank

    Operating bank subsidiary referenced in the earnings release.

Related articles

$TSBKMed

TIMBERLAND BANCORP INC (TSBK): Results of Operations and Financial Condition

TIMBERLAND BANCORP INC (TSBK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contact: Dean J. Brydon, CEO Jonathan A. Fischer, President & COO Marci A. Basich, CFO (360) 533-4747 www.timberlandbank.com Timberland Bancorp Reports Third Fiscal Quarter Net Income of $7.72 Million • Quarterly EPS Increases 9% to $0.98 from $0.90 for the Comparabl

$BMYMedAI 9/10

Bristol Myers Squibb Q3 Earnings Call Highlights

Bristol Myers Squibb (BMY) reported Q3 earnings, with eight drugs generating over $1B annually. QVANTIG revenue rose 28% to $334M, while OPDIVO fell 6% to $2.4B. BREYANZI and CAMZYOS saw significant growth. The company highlighted FDA approvals and upcoming data for new treatments. BMY plans a $2.3B Houston manufacturing campus and remains active in business development.

$TRSMed

What TriMas (TRS) Said on Its Q3 Earnings Call

TriMas (TRS) reported Q3 earnings with Packaging operating profit up 11.9% to $20.4M, but Specialty Products saw profit decline. The company expects Packaging margins to reach 14% and full-year sales growth of 4-5%. Specialty Products faces production challenges, with margins expected to improve sequentially. TriMas reaffirmed its adjusted earnings outlook of $1.60-$1.70 per share and raised its sales growth outlook to 4-6%.

$AMPHighAI 9/10

What Ameriprise Financial (AMP) Said on Its Q3 Earnings Call

Ameriprise Financial (AMP) reported Q3 earnings, highlighting organic growth and technology investments. Key points include a partnership with Huntington Bank, AI-driven tools, and asset management growth. The company returned $1B to shareholders and authorized a $5.5B buyback program. Asset management AUM rose 4% to $743B, with segment revenue up 9%. Retirement & Protection Solutions saw 24% sales growth. ROE increased to 56% from 52.8% YoY.